We are live on ! Find out more
ES

Equitec Specialists Portfolio holdings

AUM $708K
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+25.27%
3 Year Est. Return
+65.41%
5 Year Est. Return
+95.52%
10 Year Est. Return
AUM
$662M
AUM Growth
+$226M
Cap. Flow
-$69.9M
Cap. Flow %
-10.56%
Top 10 Hldgs %
61.67%
Holding
180
New
47
Increased
34
Reduced
26
Closed
38

Similar funds

Equitec Specialists's Q2 2020 Portfolio in Review

As of Q2 2020, Equitec Specialists held 180 positions worth $662M, up 52% from $436M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Equitec Specialists withdrew a net $69.9M in Q2 2020, closing 38 positions and reducing 26 holdings. Its most notable exit was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Utilities at 0.74% of assets, up from 0.11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Equitec Specialists opened a new position in Change Healthcare Inc. Tangible Equity Units worth $8.43M.

  • Equitec Specialists's largest Q2 2020 buy was Change Healthcare Inc. Tangible Equity Units: 191,841 shares worth $8.43M.
  • Equitec Specialists added most to Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A in Q2 2020, an estimated $44.3M increase.
  • Equitec Specialists's biggest Q2 2020 reduction was Clarivate, cutting an estimated $4.43M.
  • Equitec Specialists fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 in Q2 2020, selling an estimated $19.6M.
  • Equitec Specialists's ten largest holdings make up 62% of its $662M portfolio in Q2 2020.
  • Equitec Specialists opened 47 new positions and closed 38 in Q2 2020.
  • Equitec Specialists's portfolio value rose 52% quarter-over-quarter to $662M.

Based on Equitec Specialists's 13F filing for Q2 2020, filed 20 Jul 2020.